Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 3, 1996, Pages 1116-1122

  Strayer, David S ^a   Herting, Egbert ^b   Sun, Bo ^b   Robertson, Bengt ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; IMMUNOGLOBULIN G; LUNG SURFACTANT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY R5; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LUNG ALVEOLUS SURFACE TENSION; LUNG COMPLIANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RABBIT; RAT; RESPIRATORY DISTRESS SYNDROME;

EID: 0029959007     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.3.8630554     Document Type: Article

References (35)

1. Avery, M. E., and J. Mead. 1959. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 97:517-523.
2. Williams, M. C., S. Hawgood, and R. L. Hamilton. 1991. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am. J. Respir. Cell Mol. Biol. 5:41-50.
3. Kuroki, Y., R. J. Mason, and D. R. Voelker. 1988. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc. Natl. Acad. Sci. U.S.A. 85:5566-5570.
4. Strayer, D. S., S.-J. Yang, and H. H. Jerng. 1993. Surfactant protein A binding proteins: characterization and structures. J. Biol. Chem. 268:18679-18684.
5. Brogden, K. A. 1992. Ovine pulmonary surfactant induces killing of Pasteurella haemolytica, Escherichia coli, and Klebsiella pneumoniae by normal serum. Infect. Immun. 60:5182-5189.
6. Cockshutt, A. M., D. R. Absolom, and F. Possmayer. 1992. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins. Biochim. Biophys. Acta 1085:248-256.
7. Cockshutt, A. M., and F. Possmayer. 1992. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins. Biochim. Biophys. Acta 1086:63-71.
8. Frosolono, M. F., B. L. Charms, R. Pawlowski, and S. Slivka. 1970. Isolation, characterization, and surface chemistry of a surface-active fraction from dog lung. J. Lipid Res. 11:439-457.
9. Strayer, D. S., T. A. Merritt, C. Makunike, and M. Hallman. 1989. Antigenicity of low molecular weight surfactant protein. Am. J. Pathol. 134:723-732.
10. Strayer, D. S., M. Hallman, and T. A. Merritt. 1991. Immunogenicity of surfactant. I. Human alveolar surfactant. Clin. Exp. Immunol. 83:35-40.
11. Towbin, H., T. Staheiln, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:4350-4354.
12. Enhorning, G. 1977. Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol. 43:198-203.
13. Kobayashi, T., B. Robertson, G. Grossmann, K. Nitta, T. Curstedt, and Y. Suzuki. 1992. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant-associated hydrophobic protein SP-B. Acta Paediatr. 81:665-671.
14. Nilsson, R. 1979. Lung compliance and lung morphology following artificial ventilation in the premature and full-term rabbit neonate. Scand. J. Respir. Dis. 60:206-214.
15. Stevens, P. A., J. R. Wright, and J. A. Clements. 1987. Changes in quantity, composition and surface activity of alveolar surfactant at birth. J. Appl. Physiol. 63:1049-1057.
16. Sun, B., T. Kobayashi, T. Curstedt, G. Grossmann, and B. Robertson. 1991. Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur. Respir. J. 4:364-370.
17. Lachmann, B., G. Grossmann, J. Freyse, and B. Robertson. 1981. Lung-thorax compliance in the artificially ventilated premature rabbit neonate in relation to variations in inspiration:expiration ratio. Pediatr. Res. 15:833-838.
18. Lachmann, B., P. Berggren, T. Curstedt, G. Grossmann, and B. Robertson. 1982. Combined effects of surfactant substitution and prolongation of inspiration phase in artificially ventilated premature newborn rabbits. Pediatr. Res. 16:921-927.
19. Notter, R. H., J. N. Finkelstain, and R. Taubold. 1983. Comparative adsorption of natural lung surfactant, extracted phospholipids, and artificial phospholipid mixtures. Chem. Phys. Lipids 33:67-80.
20. Notter, R. H., D. L. Shapiro, B. Ohning, and J. A. Whitsett. 1987. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6,000 dalton apoprotein. Chem. Phys. Lipids 44:1-17.
21. Whitsett, J. A., R. H. Notter, B. L. Ohning, G. Ross, J. Meuth, T. Weaver, D. L. Shapiro, and B. A. Holm. 1986. Hydrophobic 6,000 dalton and its importance for biophysical activity in lung surfactant extracts. Pediatr. Res. 20:460-467.
22. Yu, S. H., and F. Possmayer. 1990. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. Biochim. Biophys. Acta 1046:233-241.
23. Hawgood, S., B. Benson, J. Schilling, D. Damm, J. Clements, and R. White. 1987. Nucleotide and amino acid sequence of pulmonary surfactant protein SP18 and evidence for cooperation between SP18 and SP23-36 in surfactant lipid activity. Proc. Natl. Acad. Sci. U.S.A. 84:66-70.
24. Revak, S., T. A. Merritt, M. Hallman, and C. Cochrane. 1986. Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo. Am. Rev. Respir. Dis. 134:1258-1265.
25. Kobayashi, T., K. Nitta, R. Takahashi, K. Kurashima, B. Robertson, and Y. Suzuki. 1991. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J. Appl. Physiol. 71:530-536.
26. Robertson, B., T. Kobayashi, M. Ganzuka, G. Grossmann, W.-Z. Li, and Y. Suzuki. 1991. Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B. Pediatr. Res. 30:239-243.
27. Eijking, E. P., D. S. Strayer, G. J. van Daal, and B. Lachmann. 1991. The effects of anti-surfactant antibodies on the course of mild respiratory distress syndrome. Pathobiology 59:96-101.
28. Seeger, W., G. Stöhr, H. R. D. Wolf, and H. Heuhof. 1985. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol. 58:326-338.
29. Fuchimukai, T., T. Fujiwara, A. Takahashi, and G. Enhorning. 1987. Artificial pulmonary surfactant inhibited by proteins. J. Appl. Physiol. 62:429-437.
30. Cockshutt, A. M., J. Weitz, and F. Possmayer. 1990. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424-8429.
31. Merritt, T. A., and M. Hallman. 1988. Surfactant replacement. Am. J. Dis. Child. 142:1333-1339.
32. Collaborative European Multicenter Study Group. 1988. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683-691.
33. Lewis, J. F., and A. H. Jobe. 1993. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:218-233.
34. Spragg, R. G., N. Gilliard, P. Richman, R. M. Smith, D. Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. 1994. Acute effects of a single dose administration of the hydrophobic components of porcine surfactant to patient with the adult respiratory distress syndrome. Chest 105:195-202.
35. Weg, J. G., R. A. Balk, S. Tharratt, S. G. Jenkinson, J. B. Shah, D. Zaccardelli, J. Horton, and E. N. Pattishall. 1994. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. J.A.M.A. 272:1433-1438.